Measures of Mortality in Coronavirus (COVID-19) Compared With SARS and MERS

ehsan allah kalteh; Aiuob Sofizadeh; Mohammad Fararouei; Mousa Ghelichi-Ghojogh; Somayeh Aljalili

doi:10.22037/jcma.v5i2.30220

Journal of Cellular & Molecular Anesthesia

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement New Publisher Announcement Reviewer and AE Registration Form Contact Us Support

APC

Authors Guide Submit Manuscript

https://doi.org/10.22037/jcma.v5i2.30220

Measures of Mortality in Coronavirus (COVID-19) Compared With SARS and MERS

Author(s):

ehsan allah kalteh

^1,*,

Aiuob Sofizadeh²,

Mohammad Fararouei

³,

Mousa Ghelichi-Ghojogh

⁴,

Somayeh Aljalili⁵

1MSc of Epidemiology, Infectious Disease Research Center, Golestan University of Medical Sciences, Gorgan, Iran

2MPH of Field Epidemiology, Infectious Disease Research Center, Golestan University of Medical Sciences, Gorgan, Iran

3HIV/AIDS research center, Shiraz University of Medical Sciences, Shiraz, Iran.

4PhD Student in Epidemiology, Student Research Commitee, Shiraz University of Medical Sciences, Shiraz, Iran.

5MD, Health Center of Kavar, Shiraz University of Medical Sciences, Shiraz, Iran.

Journal of Cellular & Molecular Anesthesia:Vol. 5, issue 2; e149621

Published online:May 13, 2020

Article type:Brief Communications

How to Cite:ehsan allah kaltehAiuob SofizadehMohammad FararoueiMousa Ghelichi-GhojoghSomayeh AljaliliMeasures of Mortality in Coronavirus (COVID-19) Compared With SARS and MERS.J Cell Mol Anesth.5(2):e149621.https://doi.org/10.22037/jcma.v5i2.30220.

Abstract

In late 2019, a novel coronavirus, now designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the cause of an outbreak of acute respiratory illness in Wuhan, a city in China. Mortality rate, case fatality rate, and Years of Potential Life Lost can be measured by determining death cases. Much of our information on mortality rates of diseases can be obtained through a regular implementation of care plans that are often developed to screen infectious diseases. In the YLL component, the higher the individuals die at an earlier age, the longer their life is lost. For COVID-19, this component refers to the simple subtraction of age at death due to COVID-19 from the standardized life expectancy for the same age in the same sex. A potential application of health summary indices is to consider the non-fatal consequences of diseases to ensure that they are taken into account in health policy making. Given that COVID-19 has a non-fatal effect on a large number of patients, the estimation of disease burden using the DALYs may be an appropriate index for achieving this goal.

Keywords

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

CrossRef 0

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

ehsan allah kalteh:[PubMed][Scholar]
Aiuob Sofizadeh:[PubMed][Scholar]
Mohammad Fararouei:[PubMed][Scholar]
Mousa Ghelichi-Ghojogh:[PubMed][Scholar]
Somayeh Aljalili:[PubMed][Scholar]